Drug intelligence / Profile preview

polyethylene glycol + bisacodyl (Hospital Universitario de Canarias)

Development stage
Unknown
Lead developer
Hospital Universitario de Canarias
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol (PEG) + bisacodyl is a combination bowel preparation regimen used to cleanse the colon prior to medical procedures such as colonoscopy. In the context of clinical research at the Hospital Universitario de Canarias (specifically the REPREP2 trial), this regimen involves an intensive high-volume approach consisting of 4 liters of PEG solution administered in split doses, supplemented with the stimulant laxative bisacodyl and a three-day fiber-free diet. Polyethylene glycol acts as an osmotic laxative, increasing the water content and volume of stool to stimulate bowel movements. Bisacodyl is a diphenylmethane derivative that acts as a stimulant laxative by directly affecting the colonic mucosa and the myenteric plexus to increase peristalsis. This specific combination is being evaluated for its efficacy in patients identified as having a high risk of poor colonic cleansing based on validated predictive scores.

Brand names
LoVol-esseLovoldyl
Other names
4 L polyethylene glycol solution plus bisacodylIntensive high-volume bowel cleansing regimenPEG + bisacodyl
02

Targets

AQP3 (Aquaporin-3 channel protein)

Beyond the preview

Go deeper on polyethylene glycol + bisacodyl (Hospital Universitario de Canarias).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol + bisacodyl (Hospital Universitario de Canarias).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call